Screener
Regeneron Pharmaceuticals REGN Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Regeneron Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: Regeneron Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 6:52 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000872589-26-000025
FAQ
- What is Regeneron Pharmaceuticals's current ratio?
- Regeneron Pharmaceuticals (REGN) reported current ratio of 3.3× in Q2 2026.
- How has Regeneron Pharmaceuticals's current ratio changed year-over-year?
- Regeneron Pharmaceuticals's current ratio decreased by 27.5% year-over-year, from 4.6× to 3.3×.
- What is the long-term trend for Regeneron Pharmaceuticals's current ratio?
- Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's current ratio has grown at a 2.6% compound annual growth rate (CAGR), from 3.6× to 4.1×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Regeneron Pharmaceuticals's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude